Accu-Chek SmartGuide CGM solution
Help your patients to manage their diabetes with our easy-to-use CGM solution.
Its predictive features may help them act before hyperglycaemia or hypoglycaemia happens.1
Help your patients to manage their diabetes with the Accu-Chek SmartGuide CGM solution
-
Real-time glucose readings
- Our easy-to-use CGM solution provides accurate2 CGM readings without daily finger-pricking3 — so your patients always know their glucose levels and whether they need attention.
-
Improving glycaemic management
- Our CGM solution shows your patients when their glucose needs attention, which could help them to improve their glycaemic management and time in range.1
-
Reducing the risk of glucose excursions
- By predicting your patients’ upcoming glucose values, our CGM solution may help them act or prepare to reduce the risk of hyper- or hypoglycaemia.1
Low Glucose Predict
30 minutes
The Low Glucose Predict feature alerts your patients when hypoglycaemia is likely to happen within 30 minutes, so they can act immediately to avoid it, or reduce its duration and severity.
What is included in our CGM solution?
-
Accu-Chek SmartGuide sensor
- A water-resistant sensor your patients can wear for up to two weeks to provide accurate,2 real-time glucose readings without finger-pricking multiple times a day.3 Applying the sensor is quick and easy with our all-in-one applicator.
-
mySugr app
-
The mySugr app helps patients to monitor their glucose and keep track of insulin injections, carbohydrate intake, and personal activities.
The app estimates where your patients’ glucose will go in the next 30 minutes, 2 hours, and during the night, so they can act or prepare to reduce the risk of hyper- or hypoglycaemia1
Seeing their CGM data supports patients to learn how their lifestyle and therapy influence their glucose levels.5,6
-
Proven Accu-Chek SmartGuide CGM sensor accuracy
Accuracy of data
Proven accuracy with a MARD of 9.2%2 — so your patients have reliable information about their glucose levels.
Insulin Dosing
The CGM solution offers easy access to accurate2 real-time glucose data, which your patients can use to dose their insulin with confidence.8
All the CGM data you need in one place
Accu-Chek Care provides all the collected data from your patients' CGM solution, so you can deliver personalised care.9
- Access CGM data transferred automatically (once connected, patient consent is required).
- View structured visualisations and reports using the latest AGP (Ambulatory Glucose Profile) standards
- Identify glucose patterns and trends.
This helps you spend less time gathering and structuring data, so you can focus on understanding your patients and responding to their needs.
CGM Learning Centre
Bite-sized content helps patients learn everything they need to know, and our customer care team is available to answer any questions.
- Guided product training
- Educational articles and videos
- Quick answers to questions

-
Guided product training
-
Educational articles and videos
-
Quick answers to questions
Speak to an Accu-Chek representative
<div class="clearfix text-formatted field field--name-field-hero-text-image-bodysugar field--type-text field--label-hidden field__item"><p>Contact us to connect with an Accu-Chek product specialist</p> </div>
The Accu-Chek SmartGuide CGM solution is intended for adults with diabetes aged 18+.
Smartphone required, not included in the solution.
MARD= Mean Absolute Relative Difference
- Herrero P et al. Glucose predictions improve glycemic control: A Digital Twin Evaluation. Diabetes Technology & Therapeutics. 2026 Mar; online doi:10.1177/15209156261432144.
- Mader JK, Waldenmaier D, Mueller-Hoffmann W, et al. Performance of a Novel Continuous Glucose Monitoring Device in People With Diabetes. J Diabetes Sci Technol. 2024 Sep;18(5):1044 1051.
- Calibration as requested by the mySugr app is required. In certain situations, your patients should use a blood glucose meter to make self-management decisions: for example, if their glucose value doesn’t match how they feel or for any therapy-related decisions while their Accu-Chek SmartGuide sensor is in Trend Mode (as well as in any other case indicated by the user’s manual or their healthcare professional).
- Glatzer T, Ringemann C, Militz D, Mueller-Hoffman W. Concept and Implementation of a Novel Continuous Glucose Predictions on Board. J Diabetes Sci Technol. 2024;18(5):1004 1008.
- Rivera-Ávila DA, Esquivel-Lu AI, Salazar-Lozano CR, Jones K, Doubova SV. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes. BMC Endocr Disord. 2021 Apr 23;21(1):79.
- Carlson AL, Mullen DM, Bergenstal RM. Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes. Diabetes Technol Ther. 2017 May;19(S2):S4-S11.
- The mySugr app predicts the general estimated glucose development within the next 2 hours (Glucose Predict), the estimated high risk of low glucose within the next 30 minutes (Low Glucose Predict), and the estimated risk of a night-time hypo for the upcoming 7 hours (Night Low Predict, active between 21:00 and 02:00).
- Calibration as requested by the mySugr app is required.
- Orive Milla N, Radiceska D, Koenig H. Clinical benefit of a diabetes management solution for HCPs: a cross-sectional analysis across ES, UK, US and BR. EASD Oct 2023. Abstract #870.
- Ehrmann D, Laviola L, Priesterroth LS, Hermanns N, Babion N, Glatzer T. Fear of Hypoglycemia and Diabetes Distress: Expected Reduction by Glucose Prediction. J Diabetes Sci Technol. 2024 Sep;18(5):1027-1034